Jump to content

Testosterone propionate/testosterone enanthate/testosterone undecylenate

Edit links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 02:25, 16 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

TP/TE/TUe
Combination of
Testosterone propionateAndrogen; Anabolic steroid
Testosterone enanthateAndrogen; Anabolic steroid
Testosterone undecylenateAndrogen; Anabolic steroid
Clinical data
Trade namesDurasteron
Other namesTP/TE/TUe
Routes of
administration		Intramuscular injection

Testosterone propionate/testosterone enanthate/testosterone undecylenate (TP/TE/TUe), sold under the brand name Durasteron, is an injectable combination medication of testosterone propionate (TP), testosterone valerate (TV), and testosterone undecylenate (TUe), all of which are androgens/anabolic steroids.[1][2] It contains 20 mg TP, 80 mg TE, and 150 mg TUe (for a total of 250 mg testosterone ester and 169.5 mg free testosterone) in oil solution and is administered by intramuscular injection at regular intervals, for instance once every 3 or 4 weeks.[3][4][5] Use of Durasteron by bodybuilders has been reported.[1][2]

Parenteral durations of androgens/anabolic steroids
Medication Form Major brand names Duration
Testosterone Aqueous suspension Andronaq, Sterotate, Virosterone 2–3 days
Testosterone propionate Oil solution Androteston, Perandren, Testoviron 3–4 days
Testosterone phenylpropionate Oil solution Testolent 8 days
Testosterone isobutyrate Aqueous suspension Agovirin Depot, Perandren M 14 days
Mixed testosterone estersa Oil solution Triolandren 10–20 days
Mixed testosterone estersb Oil solution Testosid Depot 14–20 days
Testosterone enanthate Oil solution Delatestryl 14–28 days
Testosterone cypionate Oil solution Depovirin 14–28 days
Mixed testosterone estersc Oil solution Sustanon 250 28 days
Testosterone undecanoate Oil solution Aveed, Nebido 100 days
Testosterone buciclated Aqueous suspension 20 Aet-1, CDB-1781e 90–120 days
Nandrolone phenylpropionate Oil solution Durabolin 10 days
Nandrolone decanoate Oil solution Deca Durabolin 21–28 days
Methandriol Aqueous suspension Notandron, Protandren 8 days
Methandriol bisenanthoyl acetate Oil solution Notandron Depot 16 days
Metenolone acetate Oil solution Primobolan 3 days
Metenolone enanthate Oil solution Primobolan Depot 14 days
Note: All are via i.m. injection. Footnotes: a = TP, TV, and TUe. b = TP and TKL. c = TP, TPP, TiCa, and TD. d = Studied but never marketed. e = Developmental code names. Sources: See template.

See also

References

  1. ^ a b Daher, Elizabeth F.; Silva Júnior, Geraldo B.; Queiroz, Anaiara L.; Ramos, Lysiane M. A.; Santos, Silvia Q.; Barreto, Dulce M. S.; Guimarães, Antonio Augusto C.; Barbosa, Célio A.; Franco, Luciano M.; Patrocínio, Régia M. S. V. (2009). "Acute kidney injury due to anabolic steroid and vitamin supplement abuse: report of two cases and a literature review". International Urology and Nephrology. 41 (3): 717–723. doi:10.1007/s11255-009-9571-8. ISSN 0301-1623.
  2. ^ a b Davani-Davari, Dorna; Karimzadeh, Iman; Khalili, Hossein (2019). "The potential effects of anabolic-androgenic steroids and growth hormone as commonly used sport supplements on the kidney: a systematic review". BMC Nephrology. 20 (1). doi:10.1186/s12882-019-1384-0. ISSN 1471-2369.
  3. ^ Joël, Charles A. (1960). "Zur Behandlung männlicher Fertilitätsstörungen mit hohen Androgendosen" [For the treatment of male fertility disorders with high androgen doses]. Gynecologic and Obstetric Investigation. 150 (3): 149–156. doi:10.1159/000305737. ISSN 1423-002X. [...] 20 mg Testosteronpropionat, 80 mg Testosteronheptanoat, 150 mg Testosteronundecylat (Durasteron Teva) [...]
  4. ^ Georg Arends; Heinrich Zörnig; Hermann Hager; Georg Frerichs, Walther Kern (14 December 2013). Hagers Handbuch der pharmazeutischen Praxis: Für Apotheker, Arzneimittelhersteller, Drogisten, Ärzte u. Medizinalbeamte. Springer-Verlag. pp. 1145–. ISBN 978-3-662-36329-4. At the same time, treatment with a long-acting testosterone preparation (Durasteron®) was instituted, with one injection given every four weeks.
  5. ^ Spitz, I. M.; Hirsch, H. J.; Landau, H.; Zylber-Haran, E.; Gross, V.; Rachmilewitz, E. A. (2014). "TSH secretion in thalassemia". Journal of Endocrinological Investigation. 7 (5): 495–499. doi:10.1007/BF03348456. ISSN 0391-4097. The male patients were given a long acting tes- tosterone preparation (Durasteron, Teva) 250 mg by im injection every 3 weeks for a total of 8 injections.



Stub icon

This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Testosterone_propionate/testosterone_enanthate/testosterone_undecylenate&oldid=951219552"